Trial: 202108144

A Randomized Phase II Study of CHO(E)P vs CC-486-CHO(E)P vs Duvelisib-CHO(E)P in Previously Untreated CD30 Negative Peripheral T-Cell Lymphomas

Phase

II

Principal Investigator

Mehta-Shah, Neha

Disease Site

Non-Hodgkin Lymphoma

Learn more about this study at: clinicaltrials.gov